Access based on positive interim analysis of clinical data as well as preclinical data to date PRIME designation provides a pathway for frequent and early interactions with the EMA aimed at supporting accelerated evaluation and approval
… mutation. "We are excited to announce that the second clinical study of QR-010 is now open and enrolling," said … recently has been used to assess therapeutic benefit in clinical trials of investigational agents. The study will …